ResMed | RMD - Current Liabilities


ResMed reported $1.35B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Ansell USD 468.9M 53.1M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Fisher & Paykel Healthcare NZD 497.8M 26.5M Jun/2026
Healius AUD 804.2M 203.9M Dec/2024
Integral Diagnostics AUD 85.68M 388K Jun/2024
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Nanosonics AUD 36.59M 3.2M Dec/2025
Polynovo AUD 22.81M 5.07M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
Regis Healthcare AUD 2.62B 506.08M Dec/2025
ResMed USD 1.35B 103.1M Mar/2026
Sigma Healthcare AUD 1.7B 1.33B Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Telix Pharmaceuticals AUD 242.34M 10.72M Jun/2026